Ordinary Index Rebalancing in the Solactive Obesity Index | January 2021

In the ordinary rebalance the following composition will be implemented effective open 01.02.2021:

ABIOMED INC
ANGIODYNAMICS INC
ARENA PHARMACEUTICALS INC
BIONIME CORP
CARDIOVASCULAR SYSTEMS INC
CATO CORP-CLASS A
CRYOLIFE INC
DARIOHEALTH CORP
DAVITA INC
DEXCOM INC
EKF DIAGNOSTICS HOLDINGS PLC
ESPERION THERAPEUTICS INC
FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED
FRESENIUS MEDICAL CARE AG & CO KGAA
HERBALIFE NUTRITION LTD
HUA MEDICINE
I-SENS INC
INSPIRE MEDICAL SYSTEMS INC
INSULET CORP
IRHYTHM TECHNOLOGIES INC
ITAMAR MEDICAL LTD
LEMAITRE VASCULAR INC
LEXICON PHARMACEUTICALS INC
LIFETECH SCIENTIFIC CORP
MADRIGAL PHARMACEUTICALS INC
MANNKIND CORP
MEDIFAST INC
MICROPORT SCIENTIFIC CORP
MYFIZIQ LTD
N BROWN GROUP PLC
NGM BIOPHARMACEUTICALS INC
NIPRO (NISSHO) CORP ORD
NOVO NORDISK A/S
ORAMED PHARMACEUTICALS INC
ORGENESIS INC
POXEL SA
RESMED INC-CDI
RESVERLOGIX CORP
RHYTHM PHARMACEUTICALS INC
ROCKWELL MEDICAL INC
SENSEONICS HOLDINGS INC
TAIDOC TECHNOLOGY CORP
TANDEM DIABETES CARE INC
USANA HEALTH SCIENCES INC
WW INTERNATIONAL INC